{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:11:50Z","timestamp":1793725910594,"version":"4.6.1"},"reference-count":17,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jcf.2026.04.003","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T02:56:01Z","timestamp":1776221761000},"page":"678-681","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Dupilumab in the treatment of severe chronic rhinosinusitis with nasal polyps (CRSwNP) in cystic fibrosis patients"],"prefix":"10.1016","volume":"25","author":[{"given":"Attilio","family":"Di Girolamo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8055-5892","authenticated-orcid":false,"given":"Mattia","family":"Cristallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelina Francesca","family":"Daddato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8373-0532","authenticated-orcid":false,"given":"Federico","family":"Spataro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppina","family":"Leonetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Vitullo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eustachio","family":"Nettis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcf.2026.04.003_bib0001","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/789572","article-title":"Sinonasal manifestations in cystic fibrosis","volume":"2012","author":"Oomen","year":"2012","journal-title":"Int J Otolaryngol"},{"issue":"9","key":"10.1016\/j.jcf.2026.04.003_bib0002","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1177\/000348941212100904","article-title":"Etiology of nasal polyps in cystic fibrosis: not a unimodal disease","volume":"121","author":"Steinke","year":"2012","journal-title":"Ann Otol Rhinol Laryngol"},{"issue":"9","key":"10.1016\/j.jcf.2026.04.003_bib0003","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1002\/alr.22974","article-title":"Cystic Fibrosis Foundation otolaryngology care multidisciplinary consensus recommendations","volume":"12","author":"Kimple","year":"2022","journal-title":"Int Forum Allergy Rhinol"},{"issue":"2","key":"10.1016\/j.jcf.2026.04.003_bib0004","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1177\/19458924231154061","article-title":"New concepts in barrier dysfunction in CRSwNP and emerging roles of Tezepelumab and Dupilumab","volume":"37","author":"Chiang","year":"2023","journal-title":"Am J Rhinol Allergy"},{"issue":"4","key":"10.1016\/j.jcf.2026.04.003_bib0005","first-page":"323","article-title":"Chronic rhinosinusitis in cystic fibrosis (mucoviscidosis)","volume":"51","author":"Brihaye","year":"1997","journal-title":"Acta Otorhinolaryngol Belg"},{"issue":"4","key":"10.1016\/j.jcf.2026.04.003_bib0006","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.jaip.2016.04.013","article-title":"Chronic Rhinosinusitis in patients with Cystic Fibrosis","volume":"4","author":"Hamilos","year":"2016","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jcf.2026.04.003_bib0007","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1001\/jama.284.14.1814","article-title":"Mutation in the gene responsible for cystic fibrosis and predisposition to chronic rhinosinusitis in the general population","volume":"284","author":"Wang","year":"2000","journal-title":"JAMA"},{"issue":"S7","key":"10.1016\/j.jcf.2026.04.003_bib0008","article-title":"Miraglia Del Giudice M. United airway disease","volume":"92","author":"Klain","year":"2021","journal-title":"Acta Biomed."},{"issue":"9","key":"10.1016\/j.jcf.2026.04.003_bib0009","doi-asserted-by":"crossref","first-page":"716","DOI":"10.3390\/pathogens9090716","article-title":"Allergic bronchopulmonary aspergillosis in children with cystic fibrosis: an update on the newest diagnostic tools and therapeutic approaches","volume":"9","author":"Lattanzi","year":"2020","journal-title":"Pathogens"},{"issue":"7","key":"10.1016\/j.jcf.2026.04.003_bib0010","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/alr.23557","article-title":"Beyond the lung. impact of Elexacaftor\/Tezacaftor\/Ivacaftor on sinonasal disease in children with cystic fibrosis","volume":"15","author":"Petitjean","year":"2025","journal-title":"Int Forum Allergy Rhinol."},{"issue":"5","key":"10.1016\/j.jcf.2026.04.003_bib0011","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.jcf.2022.03.002","article-title":"Elexacaftor-Tezacaftor- Ivacaftor improves sinonasal outcomes in cystic fibrosis","volume":"21","author":"Stapleton","year":"2022","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2026.04.003_bib0012","article-title":"Elexacaftor-Tezacaftor-Ivacaftor reduces revision sinus surgery in people with cystic fibrosis","author":"Lin","year":"2025","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jcf.2026.04.003_bib0013","article-title":"Chronic interleukin- 13 expression in mouse olfactory mucosa results in regional aneuronal epithelium","author":"Saraswathula","year":"2022","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jcf.2026.04.003_bib0014","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.572749","article-title":"Interleukin-13 alters tight junction proteins expression thereby compromising barrier function and dampens rhinovirus induced immune responses in nasal epithelium","volume":"8","author":"Huang","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.jcf.2026.04.003_bib0015","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJMoa2303951","article-title":"Dupilumab for COPD with type 2 inflammation indicated by eosinophil counts","volume":"389","author":"Bhatt","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcf.2026.04.003_bib0016","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01333-2019","article-title":"Anti-IL5 and anti-IL5R\u03b1 therapy for clinically significant bronchiectasis with eosinophilic endotype: a case series","volume":"55","author":"Rademacher","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jcf.2026.04.003_bib0017","article-title":"Dupilumab in chronic rhinosinusitis with nasal polyposis and concomitant cystic fibrosis: a real-life experience","author":"Govoni","year":"2024","journal-title":"Eur Arch Otorhinolaryngol"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199326000962?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199326000962?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T08:14:41Z","timestamp":1793607281000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199326000962"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1569199326000962"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2026.04.003","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dupilumab in the treatment of severe chronic rhinosinusitis with nasal polyps (CRSwNP) in cystic fibrosis patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2026.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}